A Comparison of Two Prophylactic Regimens for Hypersensitivity Reactions to Paclitaxel
Authors:
- Laurie ElitLELaurie Elit
- 1 March 2002
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 84 (3) , 420-425
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Paclitaxel-Associated Hypersensitivity Reactions: Experience of the Gynecologic Oncology Program of the Cleveland Clinic Cancer CenterJournal of Clinical Oncology, 2000
- An effective and more convenient drug regimen for prophylaxis gainst paclitaxel-associated hypersensitivity reactionsJournal of Cancer Research and Clinical Oncology, 1999
- Taxol Hypersensitivity: Rapid Retreatment Is Safe and Cost EffectiveGynecologic Oncology, 1998
- Simplified regimen for the prevention of paclitaxel-associated hypersensitivity reactions.Journal of Clinical Oncology, 1997
- Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactionsAnnals of Oncology, 1997
- Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group.Journal of Clinical Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Successful re-treatment with taxol after major hypersensitivity reactions.Journal of Clinical Oncology, 1993
- Hypersensitivity reactions from taxol.Journal of Clinical Oncology, 1990